METHOD OF TREATING ACUTE CORONARY SYNDROMES

(19)

(11)

EP 1 638 526 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	27.10.2010 Bulletin 2010/43

(45)	Mention of the grant of the patent:
	28.04.2010 Bulletin 2010/17

(21)	Application number: 04756133.7

(22)	Date of filing: 24.06.2004

(51)

International Patent Classification (IPC):

A61K 9/127^(2006.01)

A61K 31/663^(2006.01)

(86)	International application number:
	PCT/US2004/020487

(87)	International publication number:
	WO 2005/002545 (13.01.2005 Gazette 2005/02)

(54)	METHOD OF TREATING ACUTE CORONARY SYNDROMES VERFAHREN ZUR BEHANDLUNG VON AKUTEN KORONAREN SYNDROMEN PROCEDE DE TRAITEMENT DU SYNDROME CORONARIEN AIGU

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30)

Priority:

27.06.2003 US 607623
18.06.2004 US 871488

(43)	Date of publication of application:
	29.03.2006 Bulletin 2006/13

(73)	Proprietor: Biorest Ltd.
	61581 Tel-Aviv (IL)

(72)	Inventors:
	EDELMAN, Elazer, R. Brookline, MA 02445 (US) GOLOMB, Gershon 90435 Efrat (IL) DANENBERG, Haim, D. Brookline, MA 02446 (US) RICHTER, Yoram 47226 Ramat Hasharon (IL)

(74)	Representative: Kuhnen & Wacker
	Patent- und Rechtsanwaltsbüro Prinz-Ludwig-Strasse 40A 85354 Freising 85354 Freising (DE)

(56)

References cited: :

DE-A- 19 637 890
US-A1- 2002 187 184

US-A- 6 139 871
US-A1- 2002 192 157

MONKKONEN J ET AL: "Studies on liposome formulations for intra-articular delivery of clodronate" JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, vol. 35, no. 2, August 1995 (1995-08), pages 145-154, XP004037485 ISSN: 0168-3659
YLITALO R: "Bisphosphonates and atherosclerosis" GENERAL PHARMACOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 35, 2002, pages 287-296, XP002268656 ISSN: 0306-3623
BEERS M.H.; BERKOW R.: 'The Merck Manual of diagnosis and therapy', 1999, MERCK RESEARCH LABORATORIES * page 1654 - page 1681 *

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).